150 related articles for article (PubMed ID: 37227687)
1. Upregulation of helicase-like transcription factor predicts poor prognosis and facilitates hepatocellular carcinoma progression.
Cen X; Lu Y; Lu J; Zhan P; Cheng Y; Luo C; Liu J; Xie C; Wang F
Hum Cell; 2023 Jul; 36(4):1477-1484. PubMed ID: 37227687
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
3. TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10.
Liu Z; Tian Z; Cao K; Zhang B; Wen Q; Zhou X; Yang W; Wang T; Shi H; Wang R
J Cell Mol Med; 2019 Jan; 23(1):70-82. PubMed ID: 30450735
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract][Full Text] [Related]
5. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion.
Li L; Dong L; Qu X; Jin S; Lv X; Tan G
Int J Oncol; 2016 Apr; 48(4):1639-49. PubMed ID: 26892350
[TBL] [Abstract][Full Text] [Related]
8. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
9. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma.
Dai B; Zhang X; Shang R; Wang J; Yang X; Zhang H; Liu Q; Wang D; Wang L; Dou K
Cell Commun Signal; 2018 Dec; 16(1):99. PubMed ID: 30545369
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
11. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
Yan TH; Qiu C; Sun J; Li WH
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
[TBL] [Abstract][Full Text] [Related]
12. miR‑29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3.
Liang Y; Li E; Min J; Gong C; Gao J; Ai J; Liao W; Wu L
Oncol Rep; 2018 Dec; 40(6):3261-3272. PubMed ID: 30272306
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Aristaless-Like Homeobox-4 Inhibits Proliferation, Invasion, and EMT in Hepatocellular Carcinoma Cells.
Shi Y; Sun X; He X
Oncol Res; 2017 Jan; 25(1):11-18. PubMed ID: 28081728
[TBL] [Abstract][Full Text] [Related]
17. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
18. Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR-5095 from MBD2.
E C; Li C; Li H; Yang J
J Cell Physiol; 2019 Aug; 234(10):18504-18512. PubMed ID: 30912130
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12.
Zhang W; Liu K; Liu S; Ji B; Liu Y
Oncol Rep; 2018 Dec; 40(6):3585-3592. PubMed ID: 30542724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]